I. Contraindications
- Bacterial, fungal, syphilis, viral skin infections, and animal skin diseases (such as scabies).
- Those allergic to this medication.
- Perforated eczematous otitis externa at the tympanic membrane site.
- Ulcers caused by burns or frostbite of second degree or higher (excluding Behcet’s disease).
II. Warnings and Precautions
- Patients with eczema or dermatitis should be aware that if a skin infection is present, it should be treated with antibacterial or antifungal agents.
- When longer-term treatment is required, as with other topical steroids, continuous use should not exceed four weeks before the condition is reassessed.
- Pregnancy: This medication should not be used extensively during pregnancy.
- Children: Infants and children should avoid prolonged use of this medication to prevent adrenal suppression.
When used on the face and neck, use for the shortest possible time. This product is contraindicated in patients with cutaneous tuberculosis, herpes simplex, chickenpox, shingles, varicella, or those allergic to this product. If allergic skin symptoms occur after prolonged use, discontinue use immediately. If skin infections occur, and antibiotics or antifungals are used in conjunction, discontinue use until the infection is controlled. If there is a suppressive effect on the pituitary or adrenal glands, normal function will return after a short period of discontinuation. When used on the eyelids, avoid large doses and prolonged use to prevent increased intraocular pressure. When using steroids to treat psoriasis, pustular eczema and erythroderma may occasionally occur. This product is generally well-tolerated, but if these occur, discontinue use immediately. Prolonged or inappropriate use of topical corticosteroids can lead to rebound reactions (topical steroid withdrawal) after treatment cessation. Severe rebound reactions may extend beyond the initial treatment site, and symptoms may include dermatitis with intense redness, stinging, and burning sensations, particularly on delicate skin areas such as the face and curved surfaces. If these symptoms reappear within days to weeks after successful treatment, a rebound reaction should be suspected. If resuming topical corticosteroid use is necessary, carefully assess the clinical benefits and risks, or consider alternative treatment options.
III. Precautions for Special Groups
IV. Important Clinical Side Effects / Adverse Reactions
Skin and Subcutaneous Tissue Diseases – Withdrawal Reactions (Frequency Unknown): Skin redness, which may spread beyond the initial treatment area, burning or stinging sensation, itching, skin peeling, and oozing.
